Cargando…

PREVALENCE OF GERMLINE MUTATIONS IN CANCER GENES AMONG PANCREATIC CANCER PATIENTS WITH POSITIVE FAMILY HISTORY

BACKGROUND: Panel-based genetic testing has identified increasing numbers of patients with pancreatic ductal adenocarcinoma (PDAC) who carry germline mutations. However, small sample sizes or number of genes evaluated limit prevalence estimates of these mutations. We estimated prevalence of mutation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaffee, Kari G., Oberg, Ann L., McWilliams, Robert R., Majithia, Neil, Allen, Brian A., Kidd, John, Singh, Nanda, Hartman, Anne-Renee, Wenstrup, Richard J., Petersen, Gloria M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760284/ https://www.ncbi.nlm.nih.gov/pubmed/28726808 http://dx.doi.org/10.1038/gim.2017.85

Ejemplares similares

Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history
por: Breitkopf, Carmen Radecki, et al.
Publicado: (2012)

BRCA1, BRCA2, PALB2, and CDKN2A Mutations in Familial Pancreatic Cancer (FPC): A PACGENE Study
por: Zhen, David B., et al.
Publicado: (2014)

Germline mutations in Japanese familial pancreatic cancer patients
por: Takai, Erina, et al.
Publicado: (2016)

Natural history of SPINK1 germline mutation related-pancreatitis
por: Muller, Nelly, et al.
Publicado: (2019)

Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer
por: Andersson, Ulrika, et al.
Publicado: (2014)

Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer
por: Li, Liang, et al.
Publicado: (2016)

Germline DNA damage repair gene mutations in pancreatic cancer patients with personal/family histories of pancreas/breast/ovarian/prostate cancer in a Japanese population
por: Hata, Tatsuo, et al.
Publicado: (2021)

Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls
por: Pedersen, Katrina S., et al.
Publicado: (2011)

Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care
por: Casolino, Raffaella, et al.
Publicado: (2022)

Do Variants Associated with Susceptibility to Pancreatic Cancer and Type 2 Diabetes Reciprocally Affect Risk?
por: Wu, Lang, et al.
Publicado: (2015)

Cancer Spectrum, Family History of Cancer and Overall Survival in Men with Germline BRCA1 or BRCA2 Mutations
por: Reichl, Florian, et al.
Publicado: (2021)

Pedigree based DNA sequencing pipeline for germline genomes of cancer families
por: Försti, Asta, et al.
Publicado: (2016)

Germline mutations in pancreatic cancer and potential new therapeutic options
por: Pihlak, Rille, et al.
Publicado: (2017)

Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A
por: Llach, Joan, et al.
Publicado: (2023)

Bilateral Pheochromocytoma with Germline MAX Variant without Family History
por: Hata, Shinnosuke, et al.
Publicado: (2022)

Association between Alcohol Consumption, Folate Intake, and Risk of Pancreatic Cancer: A Case-Control Study
por: Yallew, Winta, et al.
Publicado: (2017)

Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study
por: Fujitani, Hiroo, et al.
Publicado: (2023)

Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer
por: Ren, Megan, et al.
Publicado: (2021)

MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease
por: Pinto, C, et al.
Publicado: (2006)

Receptivity and preferences of pancreatic cancer family members for participating in lifestyle programs to reduce cancer risk
por: Howell, Lisa A, et al.
Publicado: (2013)

Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk
por: Hamada, Tsuyoshi, et al.
Publicado: (2019)

Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China
por: Yin, Lingdi, et al.
Publicado: (2022)

Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake
por: Ramsey, Mitchell L., et al.
Publicado: (2022)

A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants
por: Earl, Julie, et al.
Publicado: (2020)

Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer
por: Zhu, Lizhen, et al.
Publicado: (2022)

Family History of Head and Neck Cancers
por: Li, Xinjun, et al.
Publicado: (2021)

Presymptomatic Identification of CDH1 Germline Mutation in a Healthy Korean Individual with Family History of Gastric Cancer
por: Choi, Hyun-Jung, et al.
Publicado: (2014)

Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes
por: Fernandes, Gabriela C., et al.
Publicado: (2016)

The role of microbiome in pancreatic cancer
por: Li, Jenny Jing, et al.
Publicado: (2021)

Germline Variants of Prostate Cancer in Japanese Families
por: Hayano, Takahide, et al.
Publicado: (2016)

Family-based germline sequencing in children with cancer
por: Kuhlen, Michaela, et al.
Publicado: (2018)

Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants
por: Murali, Krithika, et al.
Publicado: (2021)

Synchronous Onset of Breast and Pancreatic Cancers: Results of Germline and Somatic Genetic Analysis
por: Castro, Michael, et al.
Publicado: (2016)

Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma
por: Fountzilas, Elena, et al.
Publicado: (2021)

A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer
por: Astiazaran-Symonds, Esteban, et al.
Publicado: (2021)

Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake
por: Golan, Talia, et al.
Publicado: (2023)

Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients
por: Wieme, Greet, et al.
Publicado: (2021)

Clinically relevant combined effect of polygenic background, rare pathogenic germline variants, and family history on colorectal cancer incidence
por: Hassanin, Emadeldin, et al.
Publicado: (2023)

Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer
por: Macklin, Sarah K., et al.
Publicado: (2018)

A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition
por: Horn, Isaac P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hv4cper3kqii519gh4phme72vg